touchpodcast

touchPODCAST

Science EN ↓ 546 episodes

Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005!We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare Professionals globally, by translating published data into easily digestible and timely updatesHome...

Author

touchpodcast

Category

Science

Podcast website

touchpodcast.podbean.com

Latest episode

Jul 9, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 5M+ downloads · 4.8 rating iOS soon

Episodes

Higher-risk MDS and newly diagnosed AML What are the latest developments from EHA 2022 16.08.2022

touchCONGRESS for touchONCOLOGY Listen to Dr Esther Oliva (Italy) review key data presented at the EHA 2022 Hybrid Congress on recent developments in the treatment of higher-risk MDS and newly diagnosed AML; she offers her expert insights on their potential impact on future clinical practice, alongside those from Prof. Michael Heuser (Germany) and Dr Yishai Ofran (Israel).  OVERVIEW Data review wi...

Advances in the first-line treatment of ES-SCLC: From clinical data to daily practice 04.08.2022

touchPANEL DISCUSSION for touchONCOLOGY Listen to a panel of leading lung cancer experts share their perspectives on recent advances in the first-line treatment of extensive-stage small cell lung cancer (ES-SCLC) and how they are changing clinical practice. The experts Dr Marina Garassino - University of Chicago, Chicago, IL, USA Dr Louis Paz-Ares - Hospital Universitario 12 de Octubre, Complutens...

Investigating KRAS-G12C inhibitors: How might they improve outcomes for patients with solid tumours? 04.08.2022

touchTALKS for touchONCOLOGY Listen to an esteemed lung cancer expert discuss KRAS mutations in solid tumours, particularly non-small cell lung cancer and colorectal cancer, and consider the role of direct KRAS-G12C inhibitors in targeting these mutations and potential strategies to overcome resistance. The expert: Prof. Tony Mok, Chinese University of Hong Kong, Hong Kong This touchPODCAST is for...

Improving outcomes for patients with advanced renal cell carcinoma 04.08.2022

touchIN CONVERSATION for touchONCOLOGY Listen to Dr Cristina Suárez, a clinician in Spain with a specialist focus on genitourinary tumors, in conversation with Dr Toni Choueiri, a renal cell carcinoma (RCC) expert. They respond to questions submitted by the HCP audience and provide their expert insights on how emerging combination therapies in the first-line setting can improve outcomes for patien...

Experts in paediatric endocrinology discuss the assessment and treatment of children with achondroplasia 03.08.2022

touchIN CONVERSATION for touchENDOCRINOLOGY Listen to Dr Nadia Merchant in conversation with Dr Andrew Dauber. They respond to questions submitted by the HCP audience and provide their expert insights on the physiology of normal and abnormal bone growth, and the assessment and treatment of children with achondroplasia. This touchPODCAST is for HCPs only. This activity is funded by an unrestricted...

Investigating KRAS-G12C inhibitors: How might they improve outcomes for patients with solid tumours? 26.07.2022

touchTALKS for touchRESPIRATORY Listen to an esteemed lung cancer expert discuss KRAS mutations in solid tumours, particularly non-small cell lung cancer and colorectal cancer, and consider the role of direct KRAS-G12C inhibitors in targeting these mutations and potential strategies to overcome resistance. The expert: Prof. Tony Mok, Chinese University of Hong Kong, Hong Kong This touchPODCAST is...

Current and emerging treatments for chronic myeloid leukaemia: What have we learnt from the EHA Hybrid Conference 2022? 20.07.2022

touchCONGRESS for touchONCOLOGY Listen to Professor Giuseppe Saglio (Italy) cover key data presented at the EHA Hybrid Conference 2022 on the efficacy and safety of current and emerging treatments for CML, and how these may influence clinical practice, as well as expert insights and interpretation from Professor François-Xavier Mahon (France) and Professor Dietger Niederwieser (Germany). Overview...

Maximizing the potential of PARP inhibitors as first-line maintenance therapy in ovarian cancer 19.07.2022

touchIN CONVERSATION for touchONCOLOGY Listen to gynaecologic oncology specialists Prof. Nicoletta Colombo and Dr Natalia R Gómez-Hidalgo discuss three key topics relating to PARP inhibitors in the first-line maintenance setting for advanced ovarian cancer – rationale for use, which patients may particularly benefit, and key factors informing PARP inhibitor selection. Discussion on these themes is...

The practicalities of eosinophilic oesophagitis management: A closer look at emerging biologic treatment options 08.07.2022

touchPANEL DISCUSSION for touchIMMUNOLOGY Listen to key experts as they discuss the pathophysiology of eosinophilic oesophagitis (EoE) and provide their perspectives on the similarities and differences in its clinical presentation in children vs adults, the transition of care from paediatric to adult services, and the current and future treatment options for patients with EoE. The experts Dr Nirma...

The practicalities of eosinophilic oesophagitis management: A closer look at emerging biologic treatment options 08.07.2022

touchPANEL DISCUSSION for touchRESPIRATORY  Listen to key experts as they discuss the pathophysiology of eosinophilic oesophagitis (EoE) and provide their perspectives on the similarities and differences in its clinical presentation in children vs adults, the transition of care from paediatric to adult services, and the current and future treatment options for patients with EoE. The experts Dr Nir...

Treatment sequencing and the benefits of DMTs 30.06.2022

touchPANEL DISCUSSION for touchNEUROLOGY Listen to a panel of leading multiple sclerosis (MS) experts discuss their perspectives on the benefits of disease-modifying therapies (DMTs) in MS, and current approaches to treatment sequencing.  The experts Prof. Gavin Giovannoni (Chair), Blizard Institute, Queen Mary University of London, UK Prof. Eva Havrdová, General Faculty Hospital, Charles Universi...

Breast cancer specialists discuss risk stratification and novel treatment strategies in high-risk HR+ HER2– early breast cancer 15.06.2022

touchPANEL DISCUSSION for touchONCOLOGY Listen to a panel of leading breast cancer specialists discuss their perspectives on risk stratification and future therapies in HR+ HER2- early breast cancer. The experts Dr Carlos Barrios - Hospital São Lucas PUCRS, Porto Alegre, Brazil Prof. Dr. med. Nadia Harbeck - University of Munich (LMU), Munich, Germany Prof. Chiun-Sheng Huang - National Taiwan Univ...

How can real-world evidence guide the management of elderly and frail patients with multiple myeloma? 13.06.2022

touchIN CONVERSATION for touchONCOLOGY Listen to Dr Randy Broun, a community oncologist and haematologist, in conversation with Dr Faith Davies, a multiple myeloma expert. They respond to questions submitted by the HCP audience and provide their expert insights on how real-world evidence can guide the management of elderly and frail patients with multiple myeloma. This touchPODCAST is for HCPs onl...

Navigating the challenges of treatment provision in recurrent/metastatic HNSCC 26.05.2022

touchPANEL DISCUSSION for touchONCOLOGY Listen to three experts discuss the treatment of recurrent/metastatic head and neck squamous cell carcinoma (HNSCC), including the latest clinical trial data and how it informs clinical practice, and how patient priorities can be established and incorporated into the care plan. The experts Prof. Lisa Licitra - Fondazione IRCCS Istituto Nazionale dei Tumori,...

Managing EoE: What options are emerging for patients? - Conversation 3 24.05.2022

touchMDT for touchIMMUNOLOGY Listen to leading experts engage in a case-based discussion on the management of EoE, covering both current practice and therapeutic options on the horizon. The multidisciplinary team Allergist/immunologist: Prof. Jonathan Spergel, USA Gastroenterologist: Prof. Arjan Bredenoord, The Netherlands Dietitian: Dr Isabel Skypala, UK This touchPODCAST is for HCPs only. This a...

Symptoms of EoE: What is the burden for patients? - Conversation 2 24.05.2022

touchMDT for touchIMMUNOLOGY Listen to a multidisciplinary team of experts as they explore the symptoms of EoE and their impact on patients in a case-based discussion of an adult newly presenting with food impaction. The multidisciplinary team  Gastroenterologist: Prof. Arjan Bredenoord, The Netherlands Allergist/immunologist: Prof. Jonathan Spergel, USA Dietitian: Dr Isabel Skypala, UK This touch...

Pathophysiology of EoE: What do we see in patients? - Conversation 1 24.05.2022

touchMDT for touchIMMUNOLOGY Listen to leading experts discuss the environmental, genetic and immunological factors that contribute to the development of eosinophilic oesophagitis.  The multidisciplinary team Allergist/immunologist: Prof. Jonathan Spergel, USA Gastroenterologist: Prof. Arjan Bredenoord, The Netherlands This touchPODCAST is for HCPs only. This activity is funded by an unrestricted...

Managing EoE: What options are emerging for patients? - Conversation 3 24.05.2022

touchMDT for touchRESPIRATORY Listen to leading experts engage in a case-based discussion on the management of EoE, covering both current practice and therapeutic options on the horizon. The multidisciplinary team Allergist/immunologist: Prof. Jonathan Spergel, USA Gastroenterologist: Prof. Arjan Bredenoord, The Netherlands Dietitian: Dr Isabel Skypala, UK This touchPODCAST is for HCPs only. This...

Symptoms of EoE: What is the burden for patients? Conversation 2 24.05.2022

touchMDT for touchRESPIRATORY Listen to a multidisciplinary team of experts as they explore the symptoms of EoE and their impact on patients in a case-based discussion of an adult newly presenting with food impaction. The multidisciplinary team  Gastroenterologist: Prof. Arjan Bredenoord, The Netherlands Allergist/immunologist: Prof. Jonathan Spergel, USA Dietitian: Dr Isabel Skypala, UK This touc...

Pathophysiology of EoE What do we see in patients - Conversation 1 24.05.2022

touchMDT for touchRESPIRATORY Listen to leading experts discuss the environmental, genetic and immunological factors that contribute to the development of eosinophilic oesophagitis.  The multidisciplinary team Allergist/immunologist: Prof. Jonathan Spergel, USA Gastroenterologist: Prof. Arjan Bredenoord, The Netherlands This touchPODCAST is for HCPs only. This activity is funded by an independent...

Experts discuss current and future best practice for the management of non-cystic fibrosis bronchiectasis 23.05.2022

touchPANEL DISCUSSION for touchRESPIRATORY Listen to three leading experts discuss current and future best practice for the management of non-cystic fibrosis bronchiectasis, including risk factors for acute exacerbations, the management of chronic infection and available and emerging pharmacotherapeutic strategies. The experts Dr Charles Daley – National Jewish Health and University of Colorado, D...

Experts discuss current and future best practice for the management of non-cystic fibrosis bronchiectasis 23.05.2022

touchPANEL DISCUSSION for touchINFECTIOUS DISEASES Listen to three leading experts discuss current and future best practice for the management of non-cystic fibrosis bronchiectasis, including risk factors for acute exacerbations, the management of chronic infection and available and emerging pharmacotherapeutic strategies. The experts Dr Charles Daley – National Jewish Health and University of Col...

MDT perspectives on later-line treatment options for CML 09.05.2022

touchMDT for touchONCOLOGY Listen to key experts from a multidisciplinary team discuss the later-line treatment options for chronic myeloid leukaemia, including T315I mutation-positive disease The multidisciplinary team Haematologist: Prof. Dr med. Andreas Hochhaus, Germany Pharmacist: Dr Bee Kim Tan, Malaysia This touchPODCAST is for HCPs only. This activity is funded by an independent medical ed...

MDT perspectives on minimizing TKI-associated toxicities in patients with CML 09.05.2022

touchMDT for touchONCOLOGY Listen to key experts from a multidisciplinary team explore how to minimize toxicities while maximizing treatment benefit for patients with chronic myeloid leukaemia The multidisciplinary team  Nurse specialist: Johan De Munter, Belgium Haematologist: Prof. Dr med. Andreas Hochhaus, Germany This touchPODCAST is for HCPs only. This activity is funded by an independent med...

MDT perspectives on maximizing quality of life for patients with CML 09.05.2022

touchMDT for touchONCOLOGY Listen to key experts from a multidisciplinary team discuss strategies to maximize the quality of life of patients with chronic myeloid leukaemia in the later-line setting The multidisciplinary team  Pharmacist: Dr Bee Kim Tan, Malaysia Nurse specialist: Johan De Munter, Belgium This touchPODCAST is for HCPs only. This activity is funded by an independent medical educati...

Listen to the touchPODCAST podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.